Cogentix Medical Inc. (CGNT) topped out in the mid-20s in 2005 and tested that resistance level in 2008. It then entered a severe downtrend that continued into the May 2016 all-time low at 71-cents. Price action since that time has carved a multi-leg recovery, with the stock recently bouncing off new support at the 200-day EMA under $2.00. Pullbacks to the blue trendline and 50-day EMA near $2.00 should be buyable, ahead of a test at the 2016 high and continued uptrend.
